10
ECIR Medical Communications 2020-2022 Scientific Communications and Medical Affairs Postdoctoral Fellowship Program

ECIR Medical Communications 2020-2022

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ECIR Medical Communications 2020-2022

ECIR MedicalCommunications2020-2022Scientific Communicationsand Medical Affairs 

Postdoctoral FellowshipProgram

Page 2: ECIR Medical Communications 2020-2022

Our Agency is comprised of a diverse group of medical

professionals with experience in academia, pharmaceutical

industry, and medical communications firms with expertise across

multiple therapeutic areas. As a scientific communications agency,

we serve as the valued conduit between our clients and their

customers. Pharmaceutical, Medical Device and Diagnostic

companies seek our guidance in executing a variety of cutting

edge strategic and tactical projects spanning early clinical

development through late stage lifecycle management. 

We are headquartered in Jacksonville, FL, but many of our

employees work remotely from across the United States. We use a

variety of technologies to work collaboratively from virtual offices

while enjoying the flexibility of working independently.

ABOUT ECIR MEDICAL

COMMUNICATIONS

Page 3: ECIR Medical Communications 2020-2022

P U R P O S E

This cut t ing edge 24-month fe l lowshipprov ides t ra in ing and exposure to var iousaspects o f    medical a f fa i r s and sc ient i f iccommunicat ions . The program i s s t ructuredto ass i s t the fe l low in ident i fy ing careeropportun i t ies wi th in pharmaceut ica lindust ry whi le learn ing and work ing in afas t -paced env i ronment .    

O V E R V I E W

Fel lows in the Medical Communicat ionsdepartment ut i l i ze the i r c l in ica l knowledgein the development of content forheal thcare- re lated publ icat ions , meet ingsand congresses , and d ig i ta l media for avar iety o f audiences . Because our c l ients ared iverse , every day br ings a new chal lengeand a new opportun i ty to learn and grow.

Page 4: ECIR Medical Communications 2020-2022

SELECT CLIENTSAs an ECIR Fellow, you will have the opportunity to work closely with

multiple companies, expanding your professional network andunderstanding of the pharmaceutical industry.

Page 5: ECIR Medical Communications 2020-2022

SELECT THERAPEUTIC AREAS

Additionally, you will have the opportunity to diversify your CV and gainexpertise in a multitude of genres across various therapeutic areas. Through

guidance and involvement in projects with high impact on healthcareprofessionals and industry partners, you will develop an unparalleled

professional acumen for pharmaceutical vocations.

Page 6: ECIR Medical Communications 2020-2022

BENJAMIN EPSTEINPHARMD, BCPS

After attending theUniversity of Florida, Dr.Epstein completed aResidency and Fellowshipbefore accepting a positionas Assistant Professor in theCollege of Medicine andPharmacy. He hadopportunities to lecturenationally andinternationally and hasauthored articles publishedin the New England Journalof Medicine, Annals ofPharmacotherapy, andother prestigious journals.In 2009, ECIR MedicalCommunications was bornunder the leadership of Dr.Epstein as CEO. Under hisdirection, the company hasconsistently deliveredindustry-shaping value tocompanies large and small.

TINA SODHAPHARMD

After working inAstraZeneca medicalaffairs, Dr. Sodha built hercareer in medicaleducation over the last 15years with experience inboth commercial andmedical affairs. Her latestwork focuses on strategicand tactical planning forHCP communications,medical affairs learningand development, thoughtleader research andidentification, and advisoryforums. As the VicePresident of ECIR MedicalCommunications, Tina isresponsible for newbusiness development,strategic support, andensuring scientific rigor andaccuracy in all materials. 

CASSIE BOZEMANPHARMD

Cassie is a MedicalDirector at ECIRCommunications, leadinga number of facets ofmedical communicationsincluding congressstrategy, advisory boardmanagement andimplementation, MSLtraining, contentdevelopment, andpublication planning.Cassie enjoys leveragingscientific acumen andcreative strategy in thecardiovascular andmetabolic therapeuticareas. Cassie earned aDoctor of Pharmacydegree from the Universityof Florida and completeda post-doctoral fellowshipin medical affairs andscientific communicationswith ECIR medicalcommunications.

FELLOWSHIP DIRECTORSAs a fellow, you will work with Dr. Benjamin Epstein, Founder and CEO 

Dr. Tina Sodha, Vice President and Dr. Cassie Bozeman, Medical Director

on a daily basis.

Page 7: ECIR Medical Communications 2020-2022

ACQUIRED SKILLS

Page 8: ECIR Medical Communications 2020-2022

ECIR Medical CommunicationsScientific Strategist

FELLOWS CORNER

The skillset and professional network our fellows develop propels them into thecareer of their choice. The following is a list of positions offered to recent

program graduates with 100% graduate placement.

ECIR Medical CommunicationsScientific Manager

MerckMedical Science Liaison

NovartisPharmacovigilance Specialist

GenentechCommercial Development

GenentechProduct Manager, Marketing

AbbVieMedical Science Liaison

NovartisMedical Science Liaison

Duke UniversityPharmacy Quality Improvement

JanssenMedical Science Liaison

Bristol Myer SquibbMedical Science Liaison

Page 9: ECIR Medical Communications 2020-2022

KEY DATES &APPLICATION PROCESS

One Fellow will be selected on a nationally competitive basis, with interviewsat the American Society of Health Systems Pharmacists (ASHP) Midyear ClinicalMeeting. Participation in the Personnel Placement Service (PPS) is required.If you are interested in the fellowship and would like to be considered for aninterview, please submit your CV, a letter of intent, and a request through PPS.3 letters of recommendation and unofficial transcripts may be sent uponrequest.

16 OCT

WEBINAR8:00 PMEST

12 NOV DEC 10 DEC JANUARY

APPLY THROUGH PPS

An informational webinar and Q&A will be held on October 16th at 8:00pm

ET and November 12th at 8:00pm ET. To attend the webinar, please sign upusing this link. Webinar login information will be sent to applicants, or youmay email us at [email protected] for more information.

**Please allow 15 minutes to download WebEx if necessary**

WEBINAR

WEBINAR8:00 PMEST

INTERVIEWSMIDYEAR

RECEPTIONinvitation only

OFFERLETTERS

ALEXANDRIA HENRYPHARMD

CHRISTOPHER ULLUMPHARMD

CONTACT

For questions regarding ECIR, the fellowship, or theapplication process, please contact the current fellows:

Alexandria Henry: [email protected] Kravtsova: [email protected] Ullum: [email protected]

ILONA KRAVTSOVAPHARMD

8-10

"By working closely with ourselect clients, I have strengthenedmy understanding of thepharmaceutical industry, whileeffectively collaborating withnumerous in-house and fieldbased partners." 

"I look forward to leveraging myclinical knowledge to providescientific support and developexpertise in therapeutic areas.I work with some of the brightestpeople in the industry and learnsomething new every day!"

"ECIR's ability to provide fellowswith a plethora of experiencesis unparalleled in industry. Thus far,I have managed projects involvingcongress strategy, healthcareprovider value proposition, andproduct portfolio evaluation."

Page 10: ECIR Medical Communications 2020-2022

NIREN SHAH, PHARMD, MBASENIOR DIRECTOR, BUSINESS

DEVELOPMENT AND STRATEGICPARTNERSHIPS , PTC THERAPEUTICS

Completing a fellowship at ECIR was the

best decision I have ever made. It

equipped me with the knowledge to run

clinical trials, become a sound educator,

and obtain a highly coveted position

within the pharmaceutical industry. The

skills that I gained continue to support

each decision that I make today. This

fellowship is among the top two

programs in the world for candidates

pursuing academia or the

pharmaceutical industry.

GERALD GUIRARD, PHARMDMEDICAL SCIENCE LIAISON, ABBVIE

The thing that really drove me to pursue the

ECIR fellowship was the chance to work with

a multitude of different pharmaceutical

companies and work in a variety of different

therapeutic areas. This truly allowed me to

build an unparalleled CV and made me an

extremely compelling candidate following

the completion of my fellowship. I was able

to parlay my expansive experiences into my

dream job and honestly do not think I

could’ve felt more prepared going into the

job application process. I also couldn’t have

asked for a more supportive leadership

team. The relationships built during my

fellowship were invaluable and ones that I

intend to carry forward for a lifetime. All in

all, if I could go back, I wouldn’t change a

thing and I know ECIR was the right choice

for me!

ALUMNI SPOTLIGHT 

I loved being a fellow at ECIR for a number of reasons, most notably

because I truly felt like I was part of a collaborative team from day 1. My

contributions were valued and I was given autonomy, yet my fellowship

directors were always available to support and guide me. This built in me

the confidence to take ownership of meaningful projects, verbalize new

solutions or ideas, and interface directly with clients on a daily basis. The

fellowship afforded me the opportunity to work with different

pharmaceutical companies, across multiple disease states, and in various

sectors of pharma. This “trifecta” of experience made me an extremely

marketable candidate for my dream job as an MSL. However, as the end of

my fellowship neared, I realized my dream job was at ECIR, and I couldn’t

be happier to work as a scientific strategist alongside a team I love!

CASSIE BOZEMAN, PHARMDMEDICAL DIRECTOR, ECIR MEDICAL COMMUNICATIONS